Prot #X052172: A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Gevokizumab in Treating Active Ulcers of Pyoderma Gangrenosum

Project: Research project

StatusFinished
Effective start/end date3/19/153/19/18

Funding

  • Clinipace, Inc. (Prot #X052172)
  • XOMA (US) LLC (Prot #X052172)